Gradient Investments’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-7,922
Closed -$185K 772
2024
Q2
$185K Sell
7,922
-5
-0.1% -$116 ﹤0.01% 334
2024
Q1
$186K Sell
7,927
-40
-0.5% -$940 ﹤0.01% 299
2023
Q4
$188K Buy
7,967
+1,314
+20% +$30K ﹤0.01% 347
2023
Q3
$151K Buy
6,653
+1,007
+18% +$23.1K ﹤0.01% 346
2023
Q2
$130K Sell
5,646
-459
-8% -$10.7K ﹤0.01% 371
2023
Q1
$143K Buy
6,105
+5,646
+1,230% +$131K ﹤0.01% 327
2022
Q4
$10.6K Buy
+459
New +$10.5K ﹤0.01% 796

Other funds holding IBD

Gradient Investments's IBD Position: Q3 2024 in Review

Gradient Investments sold out of Inspire Corporate Bond ETF (IBD) in Q3 2024, closing a stake of 7,922 shares — an estimated $185K sold.

Gradient Investments first reported a position in IBD in Q4 2022 and held it in 7 quarters. The position peaked at $188K in Q4 2023. 80 funds tracked by Wall St. Rank hold IBD as of Q3 2024.

  • Gradient Investments reported no remaining Inspire Corporate Bond ETF position as of Q3 2024 after selling out during the quarter.
  • Gradient Investments sold 7,922 Inspire Corporate Bond ETF shares in Q3 2024, an estimated $185K.
  • Gradient Investments first reported a position in Inspire Corporate Bond ETF in Q4 2022 and held it in 7 quarters.
  • Gradient Investments's Inspire Corporate Bond ETF position peaked at $188K in Q4 2023.
  • 80 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q3 2024.

Based on Gradient Investments's 13F filing for Q3 2024, filed 15 Oct 2024.